← Open Payments lookup

MATTHEW HODERLEIN: Open Payments

NPI 1811663875 · PENFIELD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,337 in 174 payments from 13 companies in 2025. Trend: 2023 $165 · 2024 $836 · 2025 $4,337

Food & beverage: $4,337
CompanyPaymentsAmount
ABBVIE INC.29$717
Vanda Pharmaceuticals Inc.23$666
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)28$513
Axsome Therapeutics, Inc.17$457
Otsuka America Pharmaceutical, Inc.17$359
Neurocrine BioSciences, Inc.14$358
Janssen Pharmaceuticals, Inc12$344
Lundbeck LLC10$273
Teva Pharmaceuticals USA, Inc.5$189
E.R. Squibb & Sons, L.L.C.3$154

Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, INGREZZA, FANAPT, SPRAVATO, HETLIOZ.

Industry payments across NY — which companies pay providers there.